Feb 29, 2016 12:30 pm UTC| Business
MENLO PARK, Calif., Feb. 29, 2016 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of...
Cytokinetics Joins Global Movement to Recognize International Rare Disease Day
Feb 29, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 29, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that it is joining forces with the European Organisation for Rare Diseases (EURORDIS) and the National Organization for Rare...
Feb 29, 2016 12:30 pm UTC| Business
NOVATO, Calif., Feb. 29, 2016 -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Week, beginning February 29, 2016, with a series of activities and events that will celebrate...
Cempra to Present at the Cowen and Company 36th Annual Healthcare Conference
Feb 29, 2016 12:30 pm UTC| Business
CHAPEL HILL, N.C., Feb. 29, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,...
Otonomy to Present at Cowen and Company Health Care Conference
Feb 29, 2016 12:30 pm UTC| Business
SAN DIEGO, Feb. 29, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...
Global Blood Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 29, 2016 -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with...
Alimera Sciences to Present at 36th Annual Cowen Healthcare Conference
Feb 29, 2016 12:30 pm UTC| Business
ATLANTA, Feb. 29, 2016 -- Alimera Sciences (NASDAQ:ALIM), a leader in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Chief Executive Officer, Dan Myers,...